CLINICAL AND PARACLINICAL CHARACTERISTICS OF WILSON’s DISEASE PATIENTS AT GASTROENTEROLOGY AND HEPATOLOGY CENTER, BACH MAI HOSPITAL, 2022-2025
Main Article Content
Abstract
Objectives: To describe the clinical and paraclinical characteristics of patients with Wilson's disease at the Center for Gastroenterology and Hepatology, Bach Mai Hospital, from 2022 to 2025. Subjects and Methods: The study included 30 patients with Wilson's disease who were diagnosed and treated at the Gastroenterology and Hepatology Center. The study design was a cross-sectional study. Results: The majority of patients were between 18 and 30 years old, accounting for 73.3%, with the youngest being 18 and the oldest being 45. The male-to-female ratio was approximately 1:1. Common gastrointestinal symptoms included jaundice, edema, and ascites, with rates of 73.3%, 46.7%, and 53.3%, respectively. Neurological symptoms and other organ involvement were rare. Serum ceruloplasmin levels decreased in all 30 patients (100%), with 38.7% having levels below 5%. The 24-hour urinary copper level was measured in 12 patients, with 11 patients showing elevated levels (36.7%) and 1 patient with a non-elevated level (3.3%). Total bilirubin was elevated and serum albumin was decreased in 23 cases, accounting for 76.7%. Kayser-Fleischer rings and typical brain lesions were present in 30% and 13.3% of patients, respectively. Conclusion: Wilson's disease presents with diverse clinical manifestations and multi-organ involvement. Most patients have decreased serum ceruloplasmin levels
Article Details
Keywords
Wilson's disease, ceruloplasmin
References
2. Schilsky ML, Roberts EA, Bronstein JM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 practice guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. n/a(n/a). doi:10.1002/hep.32801
3. Liver EA for the S of the EASL Clinical Practice Guidelines: Wilson’s disease. Journal of Hepatology. 2012;56(3):671-685. doi: 10.1016/j.jhep.2011.11.007
4. Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The Prevalence of Wilson’s Disease: An Update. Hepatology. 2020;71(2):722-732. doi:10.1002/hep.30911
5. Frydman M. Genetic aspects of Wilson’s disease. J Gastroenterol Hepatol. 1990;5(4):483-490. doi:10.1111/j.1440-1746.1990.tb01427.x
6. Phước LH, Vũ HA, Hoàng BH. Nghiên cứu đột biến gen ATP7B trên bệnh nhân Wilson người lớn. YDLS. 2021;16(5). doi:10.52389/ydls.v16i5.803
7. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long‐term outcome of Wilson’s disease: a cohort study. Gut. 2007; 56(1): 115-120. doi:10.1136/gut.2005. 087262
8. Wungjiranirun M, Sharzehi K. Wilson’s Disease. Semin Neurol. 2023;43(4):626-633. doi:10.1055/s-0043-1771465
9. Ungureanu IM, Iesanu MI, Boboc C, et al. Addressing the Challenges in the Diagnosis and Management of Pediatric Wilson’s Disease—Case Report and Literature Review. Medicina (Kaunas). 2023;59(4):786. doi:10.3390/medicina59040786
10. Quách Nguyễn Thu Thủy. Đặc điểm lâm sàng và cận lâm sàng của bệnh WILSON ở trẻ em Tại Bệnh viện Nhi Trung Ương; 2006.